CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Total Debt to Equity

OXGN's quarterly Total Debt to Equity and Total Debt, Equity growth




OXGN Total Debt to Equity (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity Change 181.28 % 25955.92 % 3041.58 % - -
Y / Y Total Debt Change 436.74 % - - - -
Total Debt to Equity MRQ 0.08 0.07 0.06 0.09 0.04
Overall Ranking # # # # #
Seq. Equity Change 4.54 % -10.59 % 252.09 % -14.53 % 9583.62 %
Seq. Total Debt Change 11.29 % 16.39 % 109.74 % 97.56 % -



Total Debt to Equity second quarter 2020 Comment
Due to net new borrowings of 11.29%, Total Debt to Equity detoriated to 0.08, above company's average Total Debt to Equity.

Within Biotechnology & Drugs industry in the second quarter 2020, 19 other companies have achieved lower Total Debt to Equity than Mateon Therapeutics Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Debt to Equity Ratio?
Where is OXGN most successful ?
Total Debt to Equity OXGN on the trailing twelve month basis
Total Debt to Equity second quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 20
Healthcare Sector # 67
Overall Market # 359


Total Debt to Equity Statistics
High Average Low
0.09 0.07 0.04
(Sep 30 2019)   (Jun 30 2019)




Financial Statements
Mateon Therapeutics Inc's Equity $ 16 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Total Debt $ 1 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Total Debt to Equity in the quarter endingJun 30 2020, within Biotechnology & Drugs Industry Total Debt to EquityJun 30 2020 MRQ Total DebtJun 30 2020 MRQ Equity
Health Discovery Corp  0.21 $ 0.212  Millions$ 1.029  Millions
Scpharmaceuticals Inc   0.19 $ 19.076  Millions$ 98.059  Millions
Surface Oncology Inc   0.16 $ 15.486  Millions$ 97.671  Millions
Tg Therapeutics inc   0.15 $ 29.433  Millions$ 194.227  Millions
Strongbridge Biopharma plc  0.15 $ 7.003  Millions$ 47.869  Millions
Vitality Biopharma Inc   0.15 $ 0.097  Millions$ 0.667  Millions
Volitionrx Ltd  0.14 $ 2.607  Millions$ 18.679  Millions
Atyr Pharma Inc  0.14 $ 4.976  Millions$ 35.938  Millions
Applied Genetic Technologies Corp  0.14 $ 9.677  Millions$ 71.016  Millions
Syndax Pharmaceuticals Inc   0.13 $ 19.896  Millions$ 147.647  Millions
Cv Sciences Inc   0.13 $ 2.906  Millions$ 21.988  Millions
Orgenesis Inc   0.12 $ 10.655  Millions$ 88.389  Millions
Capricor Therapeutics Inc   0.12 $ 3.694  Millions$ 31.654  Millions
Eidos Therapeutics Inc   0.11 $ 16.522  Millions$ 149.311  Millions
Oncocyte Corp  0.10 $ 4.104  Millions$ 39.593  Millions
G1 Therapeutics Inc   0.10 $ 19.453  Millions$ 203.845  Millions
Outlook Therapeutics Inc   0.09 $ 0.967  Millions$ 10.965  Millions
Eyenovia Inc   0.09 $ 0.729  Millions$ 8.319  Millions
Precipio Inc   0.08 $ 1.022  Millions$ 12.627  Millions
Mateon Therapeutics Inc  0.08 $ 1.223  Millions$ 15.798  Millions
Soligenix Inc   0.07 $ 0.418  Millions$ 6.031  Millions
Windtree Therapeutics Inc  0.07 $ 5.714  Millions$ 83.456  Millions
Gossamer Bio Inc   0.07 $ 28.637  Millions$ 420.324  Millions
Sun Biopharma Inc   0.06 $ 0.103  Millions$ 1.600  Millions
Obalon Therapeutics Inc  0.06 $ 0.430  Millions$ 7.178  Millions
Aim Immunotech Inc   0.05 $ 2.214  Millions$ 46.992  Millions
Q Biomed Inc   0.05 $ 0.097  Millions$ 2.113  Millions
Satsuma Pharmaceuticals Inc   0.04 $ 3.988  Millions$ 93.934  Millions
Enochian Biosciences Inc  0.03 $ 5.781  Millions$ 166.272  Millions
Pdl Biopharma Inc   0.03 $ 13.507  Millions$ 420.001  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LFVN's Profile

Stock Price

LFVN's Financials

Business Description

Fundamentals

Charts & Quotes

LFVN's News

Suppliers

LFVN's Competitors

Customers & Markets

Economic Indicators

LFVN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071